Global Regenerative Medicine Market Insights and Forecast to 2028

  • Report ID:171343
  • Industry Name: Medical Care
  • Publishing Date: Mar-22
  • No. of Pages: 125
                              
Regenerative Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Cell Therapy Tissue Engineering Biomaterial Other Segment by Application Dermatology Cardiovascular CNS Orthopedic Others By Company J & J (DePuy Synthes) Medtronic Zimmer Biomet Stryker Allergan(Acelity) MiMedx Group Organogenesis Fujifilm Cellular Dynamics Osiris Therapeutics Vcanbio CCBC Cytori Celgene Vericel Corporation Guanhao Biotech Mesoblast AMAG Pharmaceuticals (CBR) ViaCord CordLife Integra LifeSciences Nuvasive Cook Biotech Japan Tissue Engineering By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Cell Therapy 1.2.3 Tissue Engineering 1.2.4 Biomaterial 1.2.5 Other 1.3 Market by Application 1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Dermatology 1.3.3 Cardiovascular 1.3.4 CNS 1.3.5 Orthopedic 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Regenerative Medicine Market Perspective (2017-2028) 2.2 Regenerative Medicine Growth Trends by Region 2.2.1 Regenerative Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Regenerative Medicine Historic Market Size by Region (2017-2022) 2.2.3 Regenerative Medicine Forecasted Market Size by Region (2023-2028) 2.3 Regenerative Medicine Market Dynamics 2.3.1 Regenerative Medicine Industry Trends 2.3.2 Regenerative Medicine Market Drivers 2.3.3 Regenerative Medicine Market Challenges 2.3.4 Regenerative Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Regenerative Medicine Players by Revenue 3.1.1 Global Top Regenerative Medicine Players by Revenue (2017-2022) 3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Regenerative Medicine Revenue 3.4 Global Regenerative Medicine Market Concentration Ratio 3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2021 3.5 Regenerative Medicine Key Players Head office and Area Served 3.6 Key Players Regenerative Medicine Product Solution and Service 3.7 Date of Enter into Regenerative Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Regenerative Medicine Breakdown Data by Type 4.1 Global Regenerative Medicine Historic Market Size by Type (2017-2022) 4.2 Global Regenerative Medicine Forecasted Market Size by Type (2023-2028) 5 Regenerative Medicine Breakdown Data by Application 5.1 Global Regenerative Medicine Historic Market Size by Application (2017-2022) 5.2 Global Regenerative Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Regenerative Medicine Market Size (2017-2028) 6.2 North America Regenerative Medicine Market Size by Type 6.2.1 North America Regenerative Medicine Market Size by Type (2017-2022) 6.2.2 North America Regenerative Medicine Market Size by Type (2023-2028) 6.2.3 North America Regenerative Medicine Market Share by Type (2017-2028) 6.3 North America Regenerative Medicine Market Size by Application 6.3.1 North America Regenerative Medicine Market Size by Application (2017-2022) 6.3.2 North America Regenerative Medicine Market Size by Application (2023-2028) 6.3.3 North America Regenerative Medicine Market Share by Application (2017-2028) 6.4 North America Regenerative Medicine Market Size by Country 6.4.1 North America Regenerative Medicine Market Size by Country (2017-2022) 6.4.2 North America Regenerative Medicine Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Regenerative Medicine Market Size (2017-2028) 7.2 Europe Regenerative Medicine Market Size by Type 7.2.1 Europe Regenerative Medicine Market Size by Type (2017-2022) 7.2.2 Europe Regenerative Medicine Market Size by Type (2023-2028) 7.2.3 Europe Regenerative Medicine Market Share by Type (2017-2028) 7.3 Europe Regenerative Medicine Market Size by Application 7.3.1 Europe Regenerative Medicine Market Size by Application (2017-2022) 7.3.2 Europe Regenerative Medicine Market Size by Application (2023-2028) 7.3.3 Europe Regenerative Medicine Market Share by Application (2017-2028) 7.4 Europe Regenerative Medicine Market Size by Country 7.4.1 Europe Regenerative Medicine Market Size by Country (2017-2022) 7.4.2 Europe Regenerative Medicine Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Regenerative Medicine Market Size (2017-2028) 8.2 Asia-Pacific Regenerative Medicine Market Size by Type 8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Regenerative Medicine Market Share by Type (2017-2028) 8.3 Asia-Pacific Regenerative Medicine Market Size by Application 8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Regenerative Medicine Market Share by Application (2017-2028) 8.4 Asia-Pacific Regenerative Medicine Market Size by Region 8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Regenerative Medicine Market Size (2017-2028) 9.2 Latin America Regenerative Medicine Market Size by Type 9.2.1 Latin America Regenerative Medicine Market Size by Type (2017-2022) 9.2.2 Latin America Regenerative Medicine Market Size by Type (2023-2028) 9.2.3 Latin America Regenerative Medicine Market Share by Type (2017-2028) 9.3 Latin America Regenerative Medicine Market Size by Application 9.3.1 Latin America Regenerative Medicine Market Size by Application (2017-2022) 9.3.2 Latin America Regenerative Medicine Market Size by Application (2023-2028) 9.3.3 Latin America Regenerative Medicine Market Share by Application (2017-2028) 9.4 Latin America Regenerative Medicine Market Size by Country 9.4.1 Latin America Regenerative Medicine Market Size by Country (2017-2022) 9.4.2 Latin America Regenerative Medicine Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Regenerative Medicine Market Size (2017-2028) 10.2 Middle East & Africa Regenerative Medicine Market Size by Type 10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Regenerative Medicine Market Share by Type (2017-2028) 10.3 Middle East & Africa Regenerative Medicine Market Size by Application 10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Regenerative Medicine Market Share by Application (2017-2028) 10.4 Middle East & Africa Regenerative Medicine Market Size by Country 10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 J & J (DePuy Synthes) 11.1.1 J & J (DePuy Synthes) Company Details 11.1.2 J & J (DePuy Synthes) Business Overview 11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction 11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022) 11.1.5 J & J (DePuy Synthes) Recent Developments 11.2 Medtronic 11.2.1 Medtronic Company Details 11.2.2 Medtronic Business Overview 11.2.3 Medtronic Regenerative Medicine Introduction 11.2.4 Medtronic Revenue in Regenerative Medicine Business (2017-2022) 11.2.5 Medtronic Recent Developments 11.3 Zimmer Biomet 11.3.1 Zimmer Biomet Company Details 11.3.2 Zimmer Biomet Business Overview 11.3.3 Zimmer Biomet Regenerative Medicine Introduction 11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022) 11.3.5 Zimmer Biomet Recent Developments 11.4 Stryker 11.4.1 Stryker Company Details 11.4.2 Stryker Business Overview 11.4.3 Stryker Regenerative Medicine Introduction 11.4.4 Stryker Revenue in Regenerative Medicine Business (2017-2022) 11.4.5 Stryker Recent Developments 11.5 Allergan(Acelity) 11.5.1 Allergan(Acelity) Company Details 11.5.2 Allergan(Acelity) Business Overview 11.5.3 Allergan(Acelity) Regenerative Medicine Introduction 11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022) 11.5.5 Allergan(Acelity) Recent Developments 11.6 MiMedx Group 11.6.1 MiMedx Group Company Details 11.6.2 MiMedx Group Business Overview 11.6.3 MiMedx Group Regenerative Medicine Introduction 11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2017-2022) 11.6.5 MiMedx Group Recent Developments 11.7 Organogenesis 11.7.1 Organogenesis Company Details 11.7.2 Organogenesis Business Overview 11.7.3 Organogenesis Regenerative Medicine Introduction 11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2017-2022) 11.7.5 Organogenesis Recent Developments 11.8 Fujifilm Cellular Dynamics 11.8.1 Fujifilm Cellular Dynamics Company Details 11.8.2 Fujifilm Cellular Dynamics Business Overview 11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction 11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022) 11.8.5 Fujifilm Cellular Dynamics Recent Developments 11.9 Osiris Therapeutics 11.9.1 Osiris Therapeutics Company Details 11.9.2 Osiris Therapeutics Business Overview 11.9.3 Osiris Therapeutics Regenerative Medicine Introduction 11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022) 11.9.5 Osiris Therapeutics Recent Developments 11.10 Vcanbio 11.10.1 Vcanbio Company Details 11.10.2 Vcanbio Business Overview 11.10.3 Vcanbio Regenerative Medicine Introduction 11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2017-2022) 11.10.5 Vcanbio Recent Developments 11.11 CCBC 11.11.1 CCBC Company Details 11.11.2 CCBC Business Overview 11.11.3 CCBC Regenerative Medicine Introduction 11.11.4 CCBC Revenue in Regenerative Medicine Business (2017-2022) 11.11.5 CCBC Recent Developments 11.12 Cytori 11.12.1 Cytori Company Details 11.12.2 Cytori Business Overview 11.12.3 Cytori Regenerative Medicine Introduction 11.12.4 Cytori Revenue in Regenerative Medicine Business (2017-2022) 11.12.5 Cytori Recent Developments 11.13 Celgene 11.13.1 Celgene Company Details 11.13.2 Celgene Business Overview 11.13.3 Celgene Regenerative Medicine Introduction 11.13.4 Celgene Revenue in Regenerative Medicine Business (2017-2022) 11.13.5 Celgene Recent Developments 11.14 Vericel Corporation 11.14.1 Vericel Corporation Company Details 11.14.2 Vericel Corporation Business Overview 11.14.3 Vericel Corporation Regenerative Medicine Introduction 11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022) 11.14.5 Vericel Corporation Recent Developments 11.15 Guanhao Biotech 11.15.1 Guanhao Biotech Company Details 11.15.2 Guanhao Biotech Business Overview 11.15.3 Guanhao Biotech Regenerative Medicine Introduction 11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022) 11.15.5 Guanhao Biotech Recent Developments 11.16 Mesoblast 11.16.1 Mesoblast Company Details 11.16.2 Mesoblast Business Overview 11.16.3 Mesoblast Regenerative Medicine Introduction 11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2017-2022) 11.16.5 Mesoblast Recent Developments 11.17 AMAG Pharmaceuticals (CBR) 11.17.1 AMAG Pharmaceuticals (CBR) Company Details 11.17.2 AMAG Pharmaceuticals (CBR) Business Overview 11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction 11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022) 11.17.5 AMAG Pharmaceuticals (CBR) Recent Developments 11.18 ViaCord 11.18.1 ViaCord Company Details 11.18.2 ViaCord Business Overview 11.18.3 ViaCord Regenerative Medicine Introduction 11.18.4 ViaCord Revenue in Regenerative Medicine Business (2017-2022) 11.18.5 ViaCord Recent Developments 11.19 CordLife 11.19.1 CordLife Company Details 11.19.2 CordLife Business Overview 11.19.3 CordLife Regenerative Medicine Introduction 11.19.4 CordLife Revenue in Regenerative Medicine Business (2017-2022) 11.19.5 CordLife Recent Developments 11.20 Integra LifeSciences 11.20.1 Integra LifeSciences Company Details 11.20.2 Integra LifeSciences Business Overview 11.20.3 Integra LifeSciences Regenerative Medicine Introduction 11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022) 11.20.5 Integra LifeSciences Recent Developments 11.21 Nuvasive 11.21.1 Nuvasive Company Details 11.21.2 Nuvasive Business Overview 11.21.3 Nuvasive Regenerative Medicine Introduction 11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2017-2022) 11.21.5 Nuvasive Recent Developments 11.22 Cook Biotech 11.22.1 Cook Biotech Company Details 11.22.2 Cook Biotech Business Overview 11.22.3 Cook Biotech Regenerative Medicine Introduction 11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2017-2022) 11.22.5 Cook Biotech Recent Developments 11.23 Japan Tissue Engineering 11.23.1 Japan Tissue Engineering Company Details 11.23.2 Japan Tissue Engineering Business Overview 11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction 11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022) 11.23.5 Japan Tissue Engineering Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Cell Therapy Table 3. Key Players of Tissue Engineering Table 4. Key Players of Biomaterial Table 5. Key Players of Other Table 6. Global Regenerative Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Regenerative Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Regenerative Medicine Market Share by Region (2017-2022) Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Regenerative Medicine Market Share by Region (2023-2028) Table 12. Regenerative Medicine Market Trends Table 13. Regenerative Medicine Market Drivers Table 14. Regenerative Medicine Market Challenges Table 15. Regenerative Medicine Market Restraints Table 16. Global Regenerative Medicine Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Regenerative Medicine Revenue Share by Players (2017-2022) Table 18. Global Top Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021) Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Regenerative Medicine Product Solution and Service Table 23. Date of Enter into Regenerative Medicine Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Regenerative Medicine Revenue Market Share by Type (2017-2022) Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Regenerative Medicine Revenue Market Share by Type (2023-2028) Table 29. Global Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Regenerative Medicine Revenue Share by Application (2017-2022) Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Regenerative Medicine Revenue Share by Application (2023-2028) Table 33. North America Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Regenerative Medicine Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million) Table 63. J & J (DePuy Synthes) Company Details Table 64. J & J (DePuy Synthes) Business Overview Table 65. J & J (DePuy Synthes) Regenerative Medicine Product Table 66. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 67. J & J (DePuy Synthes) Recent Developments Table 68. Medtronic Company Details Table 69. Medtronic Business Overview Table 70. Medtronic Regenerative Medicine Product Table 71. Medtronic Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 72. Medtronic Recent Developments Table 73. Zimmer Biomet Company Details Table 74. Zimmer Biomet Business Overview Table 75. Zimmer Biomet Regenerative Medicine Product Table 76. Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 77. Zimmer Biomet Recent Developments Table 78. Stryker Company Details Table 79. Stryker Business Overview Table 80. Stryker Regenerative Medicine Product Table 81. Stryker Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 82. Stryker Recent Developments Table 83. Allergan(Acelity) Company Details Table 84. Allergan(Acelity) Business Overview Table 85. Allergan(Acelity) Regenerative Medicine Product Table 86. Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 87. Allergan(Acelity) Recent Developments Table 88. MiMedx Group Company Details Table 89. MiMedx Group Business Overview Table 90. MiMedx Group Regenerative Medicine Product Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 92. MiMedx Group Recent Developments Table 93. Organogenesis Company Details Table 94. Organogenesis Business Overview Table 95. Organogenesis Regenerative Medicine Product Table 96. Organogenesis Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 97. Organogenesis Recent Developments Table 98. Fujifilm Cellular Dynamics Company Details Table 99. Fujifilm Cellular Dynamics Business Overview Table 100. Fujifilm Cellular Dynamics Regenerative Medicine Product Table 101. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 102. Fujifilm Cellular Dynamics Recent Developments Table 103. Osiris Therapeutics Company Details Table 104. Osiris Therapeutics Business Overview Table 105. Osiris Therapeutics Regenerative Medicine Product Table 106. Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 107. Osiris Therapeutics Recent Developments Table 108. Vcanbio Company Details Table 109. Vcanbio Business Overview Table 110. Vcanbio Regenerative Medicine Product Table 111. Vcanbio Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 112. Vcanbio Recent Developments Table 113. CCBC Company Details Table 114. CCBC Business Overview Table 115. CCBC Regenerative Medicine Product Table 116. CCBC Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 117. CCBC Recent Developments Table 118. Cytori Company Details Table 119. Cytori Business Overview Table 120. Cytori Regenerative Medicine Product Table 121. Cytori Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 122. Cytori Recent Developments Table 123. Celgene Company Details Table 124. Celgene Business Overview Table 125. Celgene Regenerative Medicine Product Table 126. Celgene Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 127. Celgene Recent Developments Table 128. Vericel Corporation Company Details Table 129. Vericel Corporation Business Overview Table 130. Vericel Corporation Regenerative Medicine Product Table 131. Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 132. Vericel Corporation Recent Developments Table 133. Guanhao Biotech Company Details Table 134. Guanhao Biotech Business Overview Table 135. Guanhao Biotech Regenerative Medicine Product Table 136. Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 137. Guanhao Biotech Recent Developments Table 138. Mesoblast Company Details Table 139. Mesoblast Business Overview Table 140. Mesoblast Regenerative Medicine Product Table 141. Mesoblast Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 142. Mesoblast Recent Developments Table 143. AMAG Pharmaceuticals (CBR) Company Details Table 144. AMAG Pharmaceuticals (CBR) Business Overview Table 145. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product Table 146. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 147. AMAG Pharmaceuticals (CBR) Recent Developments Table 148. ViaCord Company Details Table 149. ViaCord Business Overview Table 150. ViaCord Regenerative Medicine Product Table 151. ViaCord Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 152. ViaCord Recent Developments Table 153. CordLife Company Details Table 154. CordLife Business Overview Table 155. CordLife Regenerative Medicine Product Table 156. CordLife Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 157. CordLife Recent Developments Table 158. Integra LifeSciences Company Details Table 159. Integra LifeSciences Business Overview Table 160. Integra LifeSciences Regenerative Medicine Product Table 161. Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 162. Integra LifeSciences Recent Developments Table 163. Nuvasive Company Details Table 164. Nuvasive Business Overview Table 165. Nuvasive Regenerative Medicine Product Table 166. Nuvasive Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 167. Nuvasive Recent Developments Table 168. Cook Biotech Company Details Table 169. Cook Biotech Business Overview Table 170. Cook Biotech Regenerative Medicine Product Table 171. Cook Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 172. Cook Biotech Recent Developments Table 173. Japan Tissue Engineering Company Details Table 174. Japan Tissue Engineering Business Overview Table 175. Japan Tissue Engineering Regenerative Medicine Product Table 176. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million) Table 177. Japan Tissue Engineering Recent Developments Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Global Regenerative Medicine Market Share by Type: 2021 VS 2028 Figure 2. Cell Therapy Features Figure 3. Tissue Engineering Features Figure 4. Biomaterial Features Figure 5. Other Features Figure 6. Global Regenerative Medicine Market Share by Application: 2021 VS 2028 Figure 7. Dermatology Case Studies Figure 8. Cardiovascular Case Studies Figure 9. CNS Case Studies Figure 10. Orthopedic Case Studies Figure 11. Others Case Studies Figure 12. Regenerative Medicine Report Years Considered Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Regenerative Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Regenerative Medicine Market Share by Region: 2021 VS 2028 Figure 16. Global Regenerative Medicine Market Share by Players in 2021 Figure 17. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2021 Figure 19. North America Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Regenerative Medicine Market Size Market Share by Type (2017-2028) Figure 21. North America Regenerative Medicine Market Size Market Share by Application (2017-2028) Figure 22. North America Regenerative Medicine Market Size Share by Country (2017-2028) Figure 23. United States Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Regenerative Medicine Market Size Market Share by Type (2017-2028) Figure 27. Europe Regenerative Medicine Market Size Market Share by Application (2017-2028) Figure 28. Europe Regenerative Medicine Market Size Share by Country (2017-2028) Figure 29. Germany Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Regenerative Medicine Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Regenerative Medicine Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Regenerative Medicine Market Size Share by Region (2017-2028) Figure 39. China Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Latin America Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Regenerative Medicine Market Size Market Share by Type (2017-2028) Figure 47. Latin America Regenerative Medicine Market Size Market Share by Application (2017-2028) Figure 48. Latin America Regenerative Medicine Market Size Share by Country (2017-2028) Figure 49. Mexico Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Regenerative Medicine Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Regenerative Medicine Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Regenerative Medicine Market Size Share by Country (2017-2028) Figure 55. Turkey Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 59. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 60. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 61. Stryker Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 62. Allergan(Acelity) Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 63. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 64. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 65. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 66. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 67. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 68. CCBC Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 69. Cytori Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 70. Celgene Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 71. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 72. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 73. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 74. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 75. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 76. CordLife Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 77. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 78. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 79. Cook Biotech Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 80. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2017-2022) Figure 81. Bottom-up and Top-down Approaches for This Report Figure 82. Data Triangulation Figure 83. Key Executives Interviewed

Purchase Report

Single User 4900
Multi User 7350
Corporate User 9800
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.